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Surgical treatment of atypical Mycobacterium intracellulare infection
with chronic empyema: A case report
Kazutoshi Kotani, MD, Yoshinaru Hirose, MD, Shigeto Endo, MD, Hiroshi Yamamoto, MD, and
Shigeki Makihara, MD, Tsukubogun, Japan
Atypical mycobacterial infection in the patient withchronic empyema is very uncommon. We report acase of Mycobacterium intracellulare infection in apatient with chronic empyema treated successfully
with surgical intervention.
Clinical Summary
On April 1, 2003, an 80-year-old woman was admitted to the
hospital with a right pleural effusion. Chest radiography and chest
computed tomographic scanning revealed a right thoracic effusion
(Figure 1). M intracellulare was isolated from the thoracic effusion
and the sputum. The patient was diagnosed with an M intracellu-
lare infection with a chronic empyema and an alveolar fistula. She
received drug therapy consisting of rifampin (INN: rifampicin),
ethambutol hydrochloride, enviomycin sulfate, and clarithromycin
and irrigation into a closed thoracic drainage tube.
On June 24, we performed a thoracic fenestration. The 8th, 9th,
and 10th ribs were partially resected (8 cm). The patient received
irrigation (500 mL of saline) into the thoracic fenestration daily.
On October 15, we performed a thoracoplasty with an intratho-
racic transposition of the muscle flap using the serratus anterior
and the latissimus dorsi muscles (Figure 2). The 7th, 8th, 9th, 10th,
and 11th ribs were resected. The 3 alveolar fistulas were closed with
a mattress suture into the lung and injection of gelatin-resorcin-
formalin-glutaraldehyde (GRFG) glue into the alveolar fistulas.
On postoperative day 30, the thoracic drainage tube was re-
moved, and the empyema did not recur.
The patient will receive a drug regimen consisting of rifampi-
cin, ethambutol hydrochloride, and clarithromycin for 1 year.
Discussion
A typical mycobacterial infections usually develop in the lung, and
infection outside the lung is rare.1 Atypical mycobacterial infec-
tion in the patient with chronic empyema in particular is very
uncommon.2 The pathway of atypical mycobacterial infection to
chronic empyema is unclear, but there are 2 theories about the
process.1 The first theory is development of the empyema from the
lung infection. The second theory entails the development of the
empyema after a minor trauma.
From the Department of Surgery, National Hospital Organization Minami-
Okayama Medical Center, Tsukubogun, Japan.
Received for publication Dec 28, 2004; accepted for publication Feb 3,
2005.
Address for reprints: Kazutoshi Kotani, MD, Department of Surgery, Na-
tional Hospital Organization Minami-Okayama Medical Center, 4066
Hayashimacho, Tsukubogun, 701-0304, Japan (E-mail: kk77@f7.dion.ne.jp).
J Thorac Cardiovasc Surg 2005;130:907-8
0022-5223/$30.00
Copyright © 2005 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2005.02.054
Figure 1. Chest computed tomographic scan showing a right
thoracic effusion and honeycomb lung of the right middle and
lower lobes.
Figure 2. Thoracoplasty and an intrathoracic muscle flap trans-
position using the serratus anterior and the latissimus dorsi
muscle were performed.
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The surgical management of M intracellulare infection with
chronic empyema is not established. Yamamoto and associates1
reported a case of Mycobacterium avium complex infection in a
patient with a chronic empyema, which was treated successfully
with pleuropneumonectomy. They stated that lung resection might
be performed for the surgical treatment of M intracellulare infec-
tion with chronic empyema. Pleuropneumonectomy or lobectomy
for chronic empyema, however, is very stressful. In our case, the
M intracellulare infection was cleared from the sputum after
thoracic fenestration, and therefore we performed a thoracoplasty
with an intrathoracic muscle flap transposition. This surgical treat-
ment without lung resection in cases not involving M intracellu-
lare in the sputum is preferred because the procedure is less
invasive, safer, and less stressful than surgical treatment with lung
resection.
In our case, we selected a thoracoplasty with an intrathoracic
muscle flap transposition. The residual lung changed into a hon-
eycomb lung, which was unable to expand. If the residual lung had
the ability to expand, air plombage would have been a better option
than thoracoplasty with respect to respiratory function.3
GRFG glue is a new biologic adhesive agent with a better
sealing efficacy. GRFG glue has strong adhesive properties (al-
most 5 times that of fibrin glue). Several studies have reported the
effectiveness of GRFG glue for the treatment of bronchial fistu-
las.4,5 Hasumi and colleagues4 reported the clinical experience of
GRFG glue for acute empyema with bronchopleural fistula. GRFG
glue is a useful agent for the treatment of bronchial fistulas.
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Simultaneous traumatic rupture of bilateral pulmonary hydatid cysts
Berkant Özpolat, MD,a Murat Sayın, MD,b Orhan Veli Dogan, MD,a and Yusuf Dogan, MD,b Ankara, Turkey
Hydatid disease is common in Turkey, and it is aserious problem of worldwide importance. Because ofthe elastic properties of the lung, it seldom showssigns and symptoms. The cysts are generally detected
on routine examinations incidentally or when they are compli-
cated. All hydatid cysts carry a risk of rupture, which is the most
common complication, and trauma is a one of its causes.1,2
Here we present a life-threatening complication of traumatic
bilateral ruptured hydatid cysts causing simultaneous bilateral
pneumothorax. To our knowledge, this bilateral rupture is the first
case reported in the English literature.
Clinical Summary
A 20-year-old man was brought to the emergency department
after a vehicle accident. He had diminished bilateral breath
sounds and diffuse bronchospasm on auscultation. He was
cyanotic and severely dyspneic. The computed tomographic
(CT) scan of the thorax performed at the emergency department
revealed bilateral pneumothorax and bilateral linear fibrotic
densities in both lungs (Figure 1).
Bilateral chest tube insertion was performed immediately.
After tracheal intubation, mechanical ventilation was started
because of acute respiratory failure. The patient was transferred
to the intensive care unit, and the mechanical ventilation was
continued for 2 days. Steroid therapy was given to relieve the
bronchospasm. After the expansion of both lungs, a new CT
scan was performed, showing thin-walled, air-filled cavities in
bilateral lobes with collapsed membranes that were specific for
ruptured hydatid cysts (Figure 2). Serologic test results for
hydatid disease were positive.
Chest tubes were removed at the 10th and 14th days after the
expansion of both lungs, and the patient was discharged on the
17th day. Albendazole (10 mg · kg1 · d1) therapy was started
as soon as the rupture was diagnosed, and it was continued for
6 months. No cavitary or pleural complications were observed
at the 6-month examination.
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